These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 8234040

  • 1. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B, Simon K, Gładysz A.
    Pol Tyg Lek; ; 48(11-13):268-70. PubMed ID: 8234040
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of the determination of the gamma glutamine transferase enzyme in the diagnosis of liver and biliary tract diseases].
    Golubović G, Pandey L, Stajić M, Zvenigorodska O, Jovanović R.
    Srp Arh Celok Lek; 1986; 114(11-12):1043-8. PubMed ID: 2884731
    [No Abstract] [Full Text] [Related]

  • 3. Changes of serum angiotensin I converting enzyme in patients with viral hepatitis and liver cirrhosis.
    Schweisfurth H, Wernze H.
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):207-10. PubMed ID: 225916
    [Abstract] [Full Text] [Related]

  • 4. [Lactate dehydrogenase isoenzymes in the diagnosis of hepatobiliary diseases].
    Iordanova Iu, Georgiev P.
    Vutr Boles; 1984 Jun; 23(6):55-60. PubMed ID: 6531874
    [Abstract] [Full Text] [Related]

  • 5. [Variations in serum kininase II activity in acute jaundice].
    Olivero S, Sciascia C, Mao P, Arione R, Enrichens F, Alberghina A, Festa T, Pessione E, Sanfelici G.
    Minerva Med; 1986 May 07; 77(19):793-8. PubMed ID: 3012414
    [Abstract] [Full Text] [Related]

  • 6. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases.
    Anderson N, Pollacchi A, Hayes P, Therapondos G, Newsome P, Boyter A, Smith K.
    Biomed Chromatogr; 2002 Sep 07; 16(6):365-72. PubMed ID: 12228891
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease.
    Svenberg T, Wahren B, Hammarström S.
    Clin Exp Immunol; 1979 May 07; 36(2):317-25. PubMed ID: 477033
    [Abstract] [Full Text] [Related]

  • 8. [Is there any connection between angiotensin converting enzyme activity and liver cirrhosis of alcoholic genesis?].
    Marusić M, Babić Z.
    Acta Med Croatica; 2007 Sep 07; 61(4):365-8. PubMed ID: 18044470
    [Abstract] [Full Text] [Related]

  • 9. [Vitamin A absorption test. II. Diseases of the liver, the extrahepatic biliary system and the stomach (author's transl)].
    Schröder G, Schmidt G, Esenberg K.
    Med Klin; 1975 Oct 24; 70(43):1751-4. PubMed ID: 1186579
    [Abstract] [Full Text] [Related]

  • 10. [The importance of the complement consumption reaction for the differential diagnosis of diseases of the hepatobiliary system].
    Chernous ES, Epishin AV, Likhatskaia VA, Lemke MA, Grechukh AM, Kuz'mich IuP, Bugaĭ BG.
    Vrach Delo; 1990 May 24; (5):16-8. PubMed ID: 2396384
    [Abstract] [Full Text] [Related]

  • 11. [Serum angiotensin converting enzyme in patients with primary liver carcinoma].
    Huskić J, Kulenović H, Kardum D, Babić N, Knezević Z.
    Med Arh; 1999 May 24; 53(2):61-3. PubMed ID: 10386037
    [Abstract] [Full Text] [Related]

  • 12. [5'-nucleotidase activity in the blood in chronic diseases of the liver and biliary tract].
    Loginov AS, Isakova ZS, Skobeleva TV, Kartashova NA.
    Sov Med; 1989 May 24; (1):10-2. PubMed ID: 2541511
    [Abstract] [Full Text] [Related]

  • 13. [Correlation of the amino acid status and other laboratory tests in liver and biliary tract diseases].
    Dovat P, Svircevic A, Nikolic Dovat V, Vuković V, Zivanović M.
    Acta Med Iugosl; 1975 May 24; 29(5):431-8. PubMed ID: 1199798
    [No Abstract] [Full Text] [Related]

  • 14. [Properdin system and liver diseases].
    Reissmann G.
    Z Gesamte Inn Med; 1970 Apr 01; 25(7):297-300. PubMed ID: 5521440
    [No Abstract] [Full Text] [Related]

  • 15. Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment.
    Mounajjed T, Oxentenko AS, Qureshi H, Smyrk TC.
    Am J Clin Pathol; 2013 Jan 01; 139(1):79-86. PubMed ID: 23270902
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme in diseases of the liver.
    Matsuki K, Sakata T.
    Am J Med; 1982 Oct 01; 73(4):549-51. PubMed ID: 6289663
    [Abstract] [Full Text] [Related]

  • 17. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV, Okorokov AN.
    Vrach Delo; 1982 Aug 01; (8):22-4. PubMed ID: 6755904
    [No Abstract] [Full Text] [Related]

  • 18. Update on therapy for hepatobiliary diseases.
    Kowdley KV.
    Nurse Pract; 1996 Jul 01; 21(7):78, 81-4, 86. PubMed ID: 8823789
    [Abstract] [Full Text] [Related]

  • 19. Serum angiotensin converting enzyme levels in pancreatic diseases.
    Ibiş M, Yüksel O, Yilmaz G, Köklü S, Yilmaz FM, Ertuğrul I, Uçar E, Altiparmak ME.
    Hepatogastroenterology; 2008 Jul 01; 55(86-87):1814-7. PubMed ID: 19102399
    [Abstract] [Full Text] [Related]

  • 20. Serum angiotensin converting enzyme activity in evaluation of patients with liver disease.
    Johnson DA, Diehl AM, Sjogren MH, Lazar J, Cattau EL, Smallridge RC.
    Am J Med; 1987 Aug 01; 83(2):256-60. PubMed ID: 3039843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.